ArticleFrontiers in oncology2026

TSPAN32 as a biomarker associated with radiotherapy and immune microenvironment remodeling in lung adenocarcinoma.

Guomin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.